Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tiziana Saladino"'
Autor:
Matteo Giulietti, Francesco Piva, Monia Cecati, Serena Maggio, Michele Guescini, Tiziana Saladino, Laura Scortichini, Sonia Crocetti, Miriam Caramanti, Nicola Battelli, Emanuela Romagnoli
Publikováno v:
Cells, Vol 13, Iss 6, p 479 (2024)
Extracellular vesicles (EVs) are small lipid particles secreted by almost all human cells into the extracellular space. They perform the essential function of cell-to-cell communication, and their role in promoting breast cancer progression has been
Externí odkaz:
https://doaj.org/article/1a85ca68a5274fd19fe3ea4d77b8dc0a
Autor:
Massimo Giannini, Gerardo Ferrara, Nicola Battelli, Paolo Decembrini Cognigni, Marco Capponi, Matteo Santoni, Emanuela Romagnoli, Tiziana Saladino, Stefania Guarino, Laura Foghini
Publikováno v:
Biochimica et biophysica acta. Reviews on cancer. 1869(1)
Triple-negative breast cancer (TNBC) is associated with a poor prognosis, due to its aggressive behaviour and lack of effective targeted therapies. Immunocheckpoint inhibitors, such as anti-programmed cell death 1 (PD-1) and anti-PD-ligand(L)1 agents
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5125fa47ddbdeea6712ae1daae9bc78
https://pubmed.ncbi.nlm.nih.gov/29126881
https://pubmed.ncbi.nlm.nih.gov/29126881
Autor:
Nicla La Verde, Ida Pavese, Teresa Gamucci, Nello Salesi, Elisabetta Cretella, Mariangela Ciccarese, Gabriella Farina, Arianna Pellegrino, Anna Moretti, M. Botta, Gianfranco Addamo, Paola Varese, Karen Borgonovo, Tiziana Saladino, Monica Zuradelli, Lucia Mentuccia, Elena Barbieri, Anna Iolanda Rispoli, Sheila Piva, Massimo Di Maio
Publikováno v:
Journal of Clinical Oncology. 31:e12021-e12021
e12021 Background: Skin metastases (SM) occur in 20% of metastatic breast cancer (mBC). Clinical trials rarely describe them, even if they affect quality of life and self-perception of the disease. Eribulin (E) is a new drug, approved in mBC, after a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f686733db7506720cf3a465534a89e8e
https://doi.org/10.1200/jco.2013.31.15_suppl.e12021
https://doi.org/10.1200/jco.2013.31.15_suppl.e12021
Autor:
Dania Nacciarriti, U. Torresi, Tiziana Saladino, Barbara Pistilli, Alfredo Santinelli, Cinzia Mariani, Michele Valeri, Luciano Latini, Benedetta Ferretti, Andrea Marcellusi, Giovanni Benedetti
Publikováno v:
Journal of Clinical Oncology. 31:e11616-e11616
e11616 Background: Continuing T beyond progression has become a common strategy in the treatment of human epidermal growth receptor 2- overexpressing (HER2) MBC. However, T administered for several years with concomitant chemotherapy elicits concern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7a18934513a4707ef1abda5b9798f3f
https://doi.org/10.1200/jco.2013.31.15_suppl.e11616
https://doi.org/10.1200/jco.2013.31.15_suppl.e11616
Autor:
D. Mari, Tiziana Saladino, Stefano Cascinu, Lorena Verdecchia, Rosa Rita Silva, Rossana Berardi, Mario Scartozzi, Azzurra Onofri
Publikováno v:
Scopus-Elsevier
Aims and Background Colorectal cancer is the most common gastrointestinal tumor in Western countries and is increasing in elderly patients. In recent years, new treatments based on the use of 5-fluorouracil associated with oxaliplatin or CPT-11 have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30d0b059094a7ce35f817c0dbd84d02a
http://www.scopus.com/inward/record.url?eid=2-s2.0-32844461849&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-32844461849&partnerID=MN8TOARS
Autor:
Anna Moretti, Karen Borgonovo, Monica Zuradelli, Lucia Mentuccia, Gianfranco Addamo, Elena Barbieri, Massimo Di Maio, Elisabetta Cretella, Serena Girelli, Tiziana Saladino, Mariangela Ciccarese, Ida Pavese, Sheila Piva, Arianna Pellegrino, Nello Salesi, Anna Iolanda Rispoli, Teresa Gamucci, M. Botta, Paola Varese, Maria Chiara Dazzani, Nicla La Verde, Elena Silvia Traverso, Gabriella Farina
Publikováno v:
Scopus-Elsevier
Aim: This observational study evaluated the behavior and outcome of cutaneous breast cancer metastasis treated with eribulin. Patients & methods: From November 2012 to January 2013, oncologists completed a database with patient, tumor and treatment c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12f375497ab56c6756818862cf65d9c4
http://www.scopus.com/inward/record.url?eid=2-s2.0-84903686115&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84903686115&partnerID=MN8TOARS